mci 154 has been researched along with atenolol in 1 studies
| Studies (mci 154) | Trials (mci 154) | Recent Studies (post-2010) (mci 154) | Studies (atenolol) | Trials (atenolol) | Recent Studies (post-2010) (atenolol) |
|---|---|---|---|---|---|
| 65 | 1 | 0 | 5,473 | 1,950 | 852 |
| Protein | Taxonomy | mci 154 (IC50) | atenolol (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.7468 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, T; Hashimoto, H; Hosono, M; Nunoki, K; Sato, Y; Satoh, K; Taira, N | 1 |
1 other study(ies) available for mci 154 and atenolol
| Article | Year |
|---|---|
Improvement of pentobarbital-induced heart failure by MCI-154, a novel and potent cardiotonic agent, in the dog heart-lung preparation.
Topics: Animals; Atenolol; Blood Pressure; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dogs; Female; Heart Failure; Heart Rate; In Vitro Techniques; Male; Pentobarbital; Pyridazines | 1988 |